{"id":"atorvastatin-generic-lipitor","safety":{"commonSideEffects":[{"rate":"2-3","effect":"Muscle pain or myalgia"},{"rate":"1-3","effect":"Elevated liver enzymes (ALT/AST)"},{"rate":"1-2","effect":"Headache"},{"rate":"<0.1","effect":"Rhabdomyolysis (rare)"}]},"_chembl":{"chemblId":"CHEMBL1487","moleculeType":"Small molecule","molecularWeight":"558.65"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By blocking HMG-CoA reductase, atorvastatin decreases hepatic cholesterol production and upregulates LDL receptors on liver cells, enhancing clearance of LDL cholesterol from circulation. This leads to reduced plasma LDL cholesterol concentrations and decreased cardiovascular risk in patients with hyperlipidemia and those at risk for atherosclerotic disease.","oneSentence":"Atorvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels in the blood.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:42:45.407Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia and mixed dyslipidemia"},{"name":"Prevention of cardiovascular disease in patients at high risk"},{"name":"Acute coronary syndrome"},{"name":"Coronary heart disease"}]},"trialDetails":[{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT01600170","phase":"PHASE4","title":"Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2013-01","conditions":"HIV Dementia","enrollment":11},{"nctId":"NCT04511000","phase":"PHASE4","title":"Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2017-10-11","conditions":"Hypercholesterolemia","enrollment":250},{"nctId":"NCT01624207","phase":"PHASE4","title":"The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2010-03","conditions":"Hypercholesterolemia","enrollment":376},{"nctId":"NCT01081548","phase":"PHASE4","title":"A Clinical Trial Study to Evaluate Efficacy and Safety of Atorvastatin in Korean Patients With Hypercholesterolemia","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2008-08","conditions":"Hypercholesterolemia","enrollment":17}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"HYPOAESTHESIA"},{"count":1,"reaction":"BACK PAIN"},{"count":1,"reaction":"CHILLS"},{"count":1,"reaction":"DYSGEUSIA"},{"count":1,"reaction":"DYSSTASIA"},{"count":1,"reaction":"FEELING ABNORMAL"},{"count":1,"reaction":"FEELING COLD"},{"count":1,"reaction":"GINGIVAL SWELLING"},{"count":1,"reaction":"HIGH DENSITY LIPOPROTEIN DECREASED"},{"count":1,"reaction":"MIDDLE INSOMNIA"}],"_approvalHistory":[],"publicationCount":35,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Atorvastatin (generic Lipitor)","genericName":"Atorvastatin (generic Lipitor)","companyName":"University of Pennsylvania","companyId":"university-of-pennsylvania","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Atorvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels in the blood. Used for Hypercholesterolemia and mixed dyslipidemia, Prevention of cardiovascular disease in patients at high risk, Acute coronary syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}